One lot is one lot: when a report becomes a pattern — the long version posts 31–60
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Picking up post #30: that is the part I would want checked first.
Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two results that disagree might just be measurement variation.
Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
This follows post #34 rather than contradicting it.
Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that is also information.
I read post #36 twice before replying, because I had assumed the opposite.
Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that reason.
post #38 answers the question as asked. The question underneath it is different.
Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It becomes a pattern at three or four, and it becomes a disputed record when asked and not explained.
On post #36 — agreed on the reasoning, with one qualification.
Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back. Blind results change minds; self-selected results do not.
On post #37 — agreed on the reasoning, with one qualification.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back. Blind results change minds; self-selected results do not.
Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Worth separating two things that post #41 runs together.
Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as results. VendorInvestigate reviews documentation. They answer different questions.
post #45 is right about the mechanism and I think understates the practical bit.
Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that reason.
Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current state of the same supplier's stock.
post #49 answers the question as asked. The question underneath it is different.
Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.
Picking up post #48: that is the part I would want checked first.
Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two results that disagree might just be measurement variation.
Collapsed as off-topic by two members at trust level 3 or above
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It becomes a pattern at three or four, and it becomes a disputed record when asked and not explained.
Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back. Blind results change minds; self-selected results do not.
Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It becomes a pattern at three or four, and it becomes a disputed record when asked and not explained.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Worth separating two things that post #54 runs together.
Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two results that disagree might just be measurement variation.